Publication:
Molecular regulation of concomitant lower urinary tract symptoms and erectile dysfunction in pelvic ischemia

dc.contributor.coauthorChoi, Han-Pil
dc.contributor.coauthorAzadzoi, Kazem M.
dc.contributor.kuauthorTarcan, Tufan
dc.contributor.kuprofileOther
dc.contributor.schoolcollegeinstituteSchool of Medicine
dc.contributor.yokid173289
dc.date.accessioned2024-11-09T23:29:15Z
dc.date.issued2022
dc.description.abstractAging correlates with greater incidence of lower urinary tract symptoms (LUTS) and erectile dysfunction (ED) in the male population where the pathophysiological link remains elusive. The incidence of LUTS and ED correlates with the prevalence of vascular risk factors, implying potential role of arterial disorders in concomitant development of the two conditions. Human studies have revealed lower bladder and prostate blood flow in patients with LUTS suggesting that the severity of LUTS and ED correlates with the severity of vascular disorders. A close link between increased prostatic vascular resistance and greater incidence of LUTS and ED has been documented. Experimental models of atherosclerosis-induced chronic pelvic ischemia (CPI) showed increased contractile reactivity of prostatic and bladder tissues, impairment of penile erectile tissue relaxation, and simultaneous development of detrusor overactivity and ED. In the bladder, short-term ischemia caused overactive contractions while prolonged ischemia provoked degenerative responses and led to underactivity. CPI compromised structural integrity of the bladder, prostatic, and penile erectile tissues. Downstream molecular mechanisms appear to involve cellular stress and survival signaling, receptor modifications, upregulation of cytokines, and impairment of the nitric oxide pathway in cavernosal tissue. These observations may suggest pelvic ischemia as an important contributing factor in LUTS-associated ED. The aim of this narrative review is to discuss the current evidence on CPI as a possible etiologic mechanism underlying LUTS-associated ED.
dc.description.indexedbyWoS
dc.description.indexedbyScopus
dc.description.indexedbyPubMed
dc.description.issue24
dc.description.openaccessYES
dc.description.publisherscopeInternational
dc.description.sponsoredbyTubitakEuN/A
dc.description.sponsorshipUnited States (U.S.) Department of Veterans Affairs Biomedical Laboratory R&D (BLRD) Service [I01 BX004372] This work was supported by Merit Review Award Number I01 BX004372 from the United States (U.S.) Department of Veterans Affairs Biomedical Laboratory R&D (BLRD) Service.
dc.description.volume23
dc.identifier.doi10.3390/ijms232415988
dc.identifier.eissn1422-0067
dc.identifier.quartileN/A
dc.identifier.scopus2-s2.0-85144544153
dc.identifier.urihttp://dx.doi.org/10.3390/ijms232415988
dc.identifier.urihttps://hdl.handle.net/20.500.14288/12031
dc.identifier.wos902584000001
dc.keywordsLower urinary tract symptoms
dc.keywordsErectile dysfunction
dc.keywordsBladder
dc.keywordsProstate
dc.keywordsAtherosclerosis
dc.keywordsIschemia
dc.keywordsOxidative stress benign prostatic hyperplasia
dc.keywordsOxidative stress
dc.keywordsContractile function
dc.keywordsBladder ischemia
dc.keywordsVascular damage
dc.keywordsBlood-flow
dc.keywordsAtherosclerosis
dc.keywordsIncontinence
dc.keywordsAssociation
dc.keywordsImpairment
dc.languageEnglish
dc.publisherMDPI
dc.sourceinternational Journal of Molecular Sciences
dc.subjectBiochemistry
dc.subjectMolecular biology
dc.subjectChemistry
dc.titleMolecular regulation of concomitant lower urinary tract symptoms and erectile dysfunction in pelvic ischemia
dc.typeReview
dspace.entity.typePublication
local.contributor.authorid0000-0002-3387-3524
local.contributor.kuauthorTarcan, Tufan

Files